Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-9-5
pubmed:abstractText
186Re-labeled chimeric monoclonal antibody U36 (cMAb U36) was recently evaluated in a phase I dose escalation study in head and neck cancer patients. All 13 patients received 99mTc-labeled cMAb U36 before 186Re-cMAb U36 radioimmunotherapy. The aim of this study was to evaluate the suitability of multiple or limited blood sampling to predict clearance, red marrow absorbed dose, and myelotoxicity of 186Re-cMAb U36.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0161-5505
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1364-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11535726-Aged, pubmed-meshheading:11535726-Algorithms, pubmed-meshheading:11535726-Antibodies, Monoclonal, pubmed-meshheading:11535726-Area Under Curve, pubmed-meshheading:11535726-Bayes Theorem, pubmed-meshheading:11535726-Bone Marrow, pubmed-meshheading:11535726-Female, pubmed-meshheading:11535726-Head and Neck Neoplasms, pubmed-meshheading:11535726-Humans, pubmed-meshheading:11535726-Male, pubmed-meshheading:11535726-Middle Aged, pubmed-meshheading:11535726-Predictive Value of Tests, pubmed-meshheading:11535726-Radioimmunotherapy, pubmed-meshheading:11535726-Radioisotopes, pubmed-meshheading:11535726-Radiotherapy Dosage, pubmed-meshheading:11535726-Recombinant Fusion Proteins, pubmed-meshheading:11535726-Regression Analysis, pubmed-meshheading:11535726-Rhenium, pubmed-meshheading:11535726-Thrombocytopenia
pubmed:year
2001
pubmed:articleTitle
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.
pubmed:affiliation
Department of Otolaryngology/Head and Neck Surgery, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies